Evidence map›Paper›PMID 41906589›Full record

ArticleJACC. Case reports2026

Nonanemic Iron Deficiency: Exercise Performance Recovery After Iron Repletion in Collegiate Athlete.

Sarah M E McErlean, Loba Alam, Aaron L Baggish, Eugene H Chung, Timothy W Churchill, Gianmichel D Corrado, Noah D H Lewis, Erin E Orchard, Katie M Stewart, James Sawalla Guseh and 1 more

Abstract readCase Reports
In one paragraph

Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sarah M E McErleanFaculty of Biology and Medicine, School of Medicine, University of Lausanne, Lausanne, Switzerland.
Loba AlamCardiovascular Disease, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Aaron L BaggishDepartment of Cardiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Eugene H ChungCardiovascular Performance Program, Mass General Brigham Heart & Vascular Institute, Massachusetts General Hospital, Boston, Massachusetts, USA.
Timothy W ChurchillCardiovascular Performance Program, Mass General Brigham Heart & Vascular Institute, Massachusetts General Hospital, Boston, Massachusetts, USA.
Gianmichel D CorradoService of Sports Medicine, Department of Orthopedics, Massachusetts General Hospital, Boston, Massachusetts, USA.
Noah D H LewisCardiovascular Performance Program, Mass General Brigham Heart & Vascular Institute, Massachusetts General Hospital, Boston, Massachusetts, USA.
Erin E OrchardDivision of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Katie M StewartCardiovascular Performance Program, Mass General Brigham Heart & Vascular Institute, Massachusetts General Hospital, Boston, Massachusetts, USA.
James Sawalla GusehCardiovascular Performance Program, Mass General Brigham Heart & Vascular Institute, Massachusetts General Hospital, Boston, Massachusetts, USA. Electronic address: jguseh@mgh.harvard.edu.
Cardiovascular Performance Program Study Group

Funding

Aortic Dilatation in Endurance Athletes: A Physiologic and Mechanistic StudyK23HL159262 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Timothy CHURCHILL · 2022 to 2026
$983k
NHLBI NIH HHS K23 HL159262
6 · The paper itself

Abstract

backgroundExercise intolerance in athletes is often attributed to cardiopulmonary or autonomic causes; however, nonanemic iron deficiency is a common and under-recognized contributor that may hinder aerobic adaptation. Ferritin thresholds used in general populations do not reflect athletes' higher physiological iron requirements. CASE SUMMARY: A 21-year-old collegiate gymnast presented with exertional intolerance, positional lightheadedness, and tachycardia. Cardiopulmonary exercise testing showed reduced aerobic capacity (peak oxygen consumption: 25.5 mL/kg/min; 67% predicted). Iron studies revealed marked deficiency (ferritin: 15 μg/L, transferrin saturation: 13%) despite normal hemoglobin (14.1 g/dL). She was treated with intravenous iron; 5 months later, iron normalized, symptoms improved, and peak oxygen consumption increased to 31.2 mL/kg/min (81% predicted). DISCUSSION: This case highlights that nonanemic iron deficiency can mimic deconditioning and dysautonomia yet is fully reversible when identified early. Physiological evidence supports using ferritin <50 μg/L to detect clinically relevant deficiency in athletes. TAKE-HOME MESSAGES: Iron deficiency without anemia should be considered early in athletes with unexplained exercise intolerance.

Indexed as

exercise intolerancefemale athleteiron deficiencypeak Vo(2)

Identifiers

PMID41906589
PMCPMC13045603

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.